showed that EPHA2 contributes to mitochondrial dynamics, autophagy, and mitophagy in cervical cancer, enhancing sensitivity to cisplatin by modulating inflammatory programmed cell death pathways (52, 53). Here, EPHA2 is linked to cervical cancer.